4.7 Article

Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation

Zengyang Yu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)

Article Ophthalmology

Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes

Xiaofei Chen et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)

Review Endocrinology & Metabolism

Functions of Muller cell-derived vascular endothelial growth factor in diabetic retinopathy

Juan-Juan Wang et al.

WORLD JOURNAL OF DIABETES (2015)

Article Endocrinology & Metabolism

The Association of Serum Vascular Endothelial Growth Factor and Ferritin in Diabetic Microvascular Disease

Li Guo et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2014)

Review Ophthalmology

Natural product inhibitors of ocular angiogenesis

Rania S. Sulaiman et al.

EXPERIMENTAL EYE RESEARCH (2014)

Article Pharmacology & Pharmacy

Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism

Chen-Yuan Gong et al.

VASCULAR PHARMACOLOGY (2014)

Review Ophthalmology

The Role of Microglia in Diabetic Retinopathy

Jeffery G. Grigsby et al.

JOURNAL OF OPHTHALMOLOGY (2014)

Article Pharmacology & Pharmacy

Role of phospholipases A2 in diabetic retinopathy: In vitro and in vivo studies

Gabriella Lupo et al.

BIOCHEMICAL PHARMACOLOGY (2013)

Review Medicine, General & Internal

VEGFA and tumour angiogenesis

L. Claesson-Welsh et al.

JOURNAL OF INTERNAL MEDICINE (2013)

Article Pharmacology & Pharmacy

Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats

Claudio Bucolo et al.

BIOCHEMICAL PHARMACOLOGY (2012)

Article Endocrinology & Metabolism

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

Joanne W. Y. Yau et al.

DIABETES CARE (2012)

Review Ophthalmology

Vascular Complications and Diabetes: Current Therapies and Future Challenges

Abbott L. Willard et al.

JOURNAL OF OPHTHALMOLOGY (2012)

Article Biochemistry & Molecular Biology

Anti-Angiogenesis Drugs in Diabetic Retinopathy

V. Swetha E. Jeganathan

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)

Article Ophthalmology

Inflammation in diabetic retinopathy

Johnny Tang et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2011)

Review Ophthalmology

A review of clinical trials of anti-VEGF agents for diabetic retinopathy

Benjamin P. Nicholson et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)

Article Medicine, General & Internal

Diabetic retinopathy

Ning Cheung et al.

LANCET (2010)

Article Biochemistry & Molecular Biology

Autocrine VEGF signaling is required for vascular homeostasis

Sunyoung Lee et al.

Article Cell Biology

Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry

Zeshan Ahmed et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)

Review Ophthalmology

Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy

Sarah X. Zhang et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2007)

Review Pharmacology & Pharmacy

Regulation of vascular genes by glucose

OI Stenina

CURRENT PHARMACEUTICAL DESIGN (2005)

Article Oncology

In vivo and in vitro evaluation of erianin, a novel anti-anglogenic agent

YQ Gong et al.

EUROPEAN JOURNAL OF CANCER (2004)